中国卫生标准管理
中國衛生標準管理
중국위생표준관리
CHINA HEALTH STANDARD MANAGEMENT
2015年
15期
101-102
,共2页
马来酸桂哌齐特%心肌缺血%临床体会
馬來痠桂哌齊特%心肌缺血%臨床體會
마래산계고제특%심기결혈%림상체회
Maleate cinepazide%Myocardial Ischemia%Clinical experience
目的:对马来酸桂哌齐特治疗心肌缺血的临床效果进行分析,并对治疗体会进行总结。方法选取于2013年3月~2015年1月在我院接受治疗的47例心肌缺血患者,根据不同的治疗方式将患者随机分为对照组和治疗组进行对照研究,对常规治疗和加用马来酸桂哌齐特治疗的临床效果进行观察比较。结果治疗组患者的治疗总有效率以及红细胞变形指数显著高于对照组,全血黏度、血浆黏度、红细胞聚集指数、红细胞压积等血流动力学指标均显著低于对照组,差异显著,具有统计学意义(P <0.05)。结论马来酸桂哌齐特治疗心肌缺血能够取得十分显著的临床效果,能显著改善患者的血流动力学,值得推广应用。
目的:對馬來痠桂哌齊特治療心肌缺血的臨床效果進行分析,併對治療體會進行總結。方法選取于2013年3月~2015年1月在我院接受治療的47例心肌缺血患者,根據不同的治療方式將患者隨機分為對照組和治療組進行對照研究,對常規治療和加用馬來痠桂哌齊特治療的臨床效果進行觀察比較。結果治療組患者的治療總有效率以及紅細胞變形指數顯著高于對照組,全血黏度、血漿黏度、紅細胞聚集指數、紅細胞壓積等血流動力學指標均顯著低于對照組,差異顯著,具有統計學意義(P <0.05)。結論馬來痠桂哌齊特治療心肌缺血能夠取得十分顯著的臨床效果,能顯著改善患者的血流動力學,值得推廣應用。
목적:대마래산계고제특치료심기결혈적림상효과진행분석,병대치료체회진행총결。방법선취우2013년3월~2015년1월재아원접수치료적47례심기결혈환자,근거불동적치료방식장환자수궤분위대조조화치료조진행대조연구,대상규치료화가용마래산계고제특치료적림상효과진행관찰비교。결과치료조환자적치료총유효솔이급홍세포변형지수현저고우대조조,전혈점도、혈장점도、홍세포취집지수、홍세포압적등혈류동역학지표균현저저우대조조,차이현저,구유통계학의의(P <0.05)。결론마래산계고제특치료심기결혈능구취득십분현저적림상효과,능현저개선환자적혈류동역학,치득추엄응용。
Objective Clinical effect of maleate cinepazide application in treatment of myocardial ischemia is to be studied and its treatment experience is to be summarized.Methods Choose 47 patients of myocardial ischemia who are treated in hospital from March 2013 to January 2015 and separate them into control group and study group according to different treatment methods; and then make an observation and comparison on patients’ treatment effects of conventional medication treatment and maleate cinepazide medication between two groups.ResultsTreatment efficacy as wel as patients’ erythrocyte deformation index in study group are quite higher than counterparts in control group, and in addition, patients’ blood viscosity and plasma viscosity, erythrocyte aggregation index, hematocrit and other hemodynamic parameters in study group are significantly lower than counterparts in control group; there is a treatment differential between two groups and such a differential has statistic value (P < 0.05).ConclusionMaleate cinepazide is of efficacy in treatment of myocardial ischemia; it is conducive to promoting patients’ hemodynamic parameters; thus, such a treatment is quite worthwhile to be promoted and applied clinicaly.